
A computer-controlled inhaler that is far more effective than the traditional one has been developed by researchers at North Carolina State University in Raleigh.
Inhaling a drug in aerosol form is an increasingly common way of treating cancers, AIDS, diabetes, and asthma, reports New Scientist.
Advertisement
However, inhalers are notoriously inefficient because at best they deliver 20 percent of their load into the lungs and at worst, they deliver less than 5 percent.
The rest gets left in the mouth and throat, or gets blown back out into the air, particularly if the user''s intake of breath is not well synchronised with the aerosol jet.
Therefore, Clement Kleinstreuer, a mechanical engineer at North Carolina State University, has developed the smart inhaler that measures air flow around its nozzle to determine the best moment to release a powdered drug to achieve maximum penetration into the lungs.
Kleinstreuer even claims that the new type of inhaler can target specific areas of the lungs with a drug.
This is done by injecting powder into different parts of the airflow, aiming the drug towards the right or left lung or even areas within each lung.
That could make inhalers far more efficient at targeting the conditions they are designed to treat.
Source: ANI
RAS/L
Advertisement
Therefore, Clement Kleinstreuer, a mechanical engineer at North Carolina State University, has developed the smart inhaler that measures air flow around its nozzle to determine the best moment to release a powdered drug to achieve maximum penetration into the lungs.
Kleinstreuer even claims that the new type of inhaler can target specific areas of the lungs with a drug.
This is done by injecting powder into different parts of the airflow, aiming the drug towards the right or left lung or even areas within each lung.
That could make inhalers far more efficient at targeting the conditions they are designed to treat.
Source: ANI
RAS/L
Advertisement
Advertisement
|
Advertisement
Latest News on IT in Healthcare

The GatorTronGPT AI tool might lead to a substantial improvement in healthcare efficiency through AI advancements.

FDA-approved two renal denervation systems mark a groundbreaking step in treating uncontrolled hypertension.

The AI system generates a report outlining the specific neural pathways impacted and their expected influence on brain functionality in individuals with autism.

Rather than being perceived as an obstacle, experts argue that the pandemic has served as a catalyst for digital transformation, especially the healthcare industry.

Novel innovation by AI helps provide a swift, yet reproducible measure of lean muscle mass in developing children.